Tectonic Therapeutic, Inc.
TECX
$21.09
-$1.29-5.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -57.98M | -53.48M | -45.82M | -43.60M | -42.82M |
| Total Depreciation and Amortization | 1.65M | 1.51M | 1.46M | 1.49M | 1.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.54M | 6.48M | 5.08M | 3.39M | 1.25M |
| Change in Net Operating Assets | -10.28M | -8.43M | -3.51M | -420.00K | -584.00K |
| Cash from Operations | -59.08M | -53.92M | -42.79M | -39.14M | -40.68M |
| Capital Expenditure | -156.00K | -203.00K | -57.00K | -147.00K | -279.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -156.00K | -203.00K | -57.00K | -147.00K | -279.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -475.00K | -475.00K | -469.00K | -473.00K | -499.00K |
| Issuance of Common Stock | 97.33M | 131.57M | 131.49M | 34.25M | 34.25M |
| Repurchase of Common Stock | -1.10M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 75.97M | 75.82M | 82.06M | -554.00K | -- |
| Cash from Financing | 171.71M | 206.91M | 213.09M | 33.22M | 33.75M |
| Foreign Exchange rate Adjustments | -8.00K | -29.00K | -44.00K | -60.00K | 16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.47M | 152.77M | 170.19M | -6.12M | -7.20M |